Schedule 13G ownership disclosure

Ironwood Pharmaceuticals Inc

Security class unavailable · CUSIP: 46333X108

Event date: 2018-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,207,015
Percent of class
8.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-18-002779
Form type
SC 13G/A
Filer
IRONWOOD PHARMACEUTICALS INC
CIK
CIK 1446847
Filed
Jul 10, 2018
Reporting period
Jun 30, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub